14h
Hosted on MSNHims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugsThe telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide ...
Hims & Hers makes its Super Bowl commercial debut in 2025 with a spot for the telehealth company's weight loss medications.
Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.
Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.
Telehealth provider Hims & Hers Health is defending its planned Super Bowl ad, which is styled as a political manifesto ...
A Super Bowl ad touting Hims & Hers Health Inc.’s copycat weight-loss drugs is getting pushback from the branded drugmakers’ ...
22hon MSNOpinion
The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...
1d
GlobalData on MSNSuper Bowl ad for copycat weight loss drugs stokes pharma power debateControversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...
Hims & Hers' Super Bowl ad for unapproved weight loss drugs faces backlash from health experts over safety concerns.
Telehealth company Hims & Hers' first Super Bowl ad is provocative and effective in building awareness of its weight loss ...
Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...
Drug industry allies are calling out a Super Bowl ad touting its weight loss medications from telehealth company Hims & Hers, claiming the spot doesn't adequately disclose safety risks of these drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results